Literature DB >> 20544166

[Minimally invasive follicular thyroid carcinoma : Not always total thyroidectomy].

M Hermann1, K Tonninger, F Kober, E-M Furtlehner, A Schultheis, N Neuhold.   

Abstract

Current treatment guidelines for follicular thyroid carcinoma (FTC) recommend total thyroidectomy, lymphadenectomy and radioiodine ablation. Considering the low malignant potential of minimally invasive follicular thyroid carcinoma (MIFTC), a limited radical therapeutic procedure may be adequate. MIFTC is an intensely discussed group of tumors and a review of the literature reveals disagreement among experts concerning the criteria for a distinct definition. Therefore, in 2005 Rosai proposed a clinically more significant classification of FTC based on the extent of capsular and vascular invasion: MIFTC with capsular invasion only, with limited (< or =3) vascular invasion, encapsulated FTC with extensive (>3) vascular invasion and broadly invasive FTC with extensive invasive growth.For the diagnosis of MIFTC a complete investigation of the encapsulated follicular lesion should be performed by the pathologist and examination of at least 10 tissue blocks is mandatory. Due to the excellent prognosis hemithyroidectomy constitutes an adequate therapeutic approach in MIFTC with capsular invasion only and may also be considered for MIFTC with limited vascular invasion. There are no indications for systematic lymphadenectomy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20544166     DOI: 10.1007/s00104-009-1884-8

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  50 in total

1.  Complications in thyroid surgery for carcinoma: one institution's surgical experience.

Authors:  Antonio Toniato; Isabella Merante Boschin; Andrea Piotto; Maria Rosa Pelizzo; Annamaria Guolo; Mirto Foletto; Eric Casalide
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

2.  Complications associated with different surgical approaches to differentiated thyroid carcinoma.

Authors:  T Steinmüller; J Klupp; S Wenking; P Neuhaus
Journal:  Langenbecks Arch Surg       Date:  1999-02       Impact factor: 3.445

3.  Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma: a study of 34 patients.

Authors:  N S Goldstein; P Czako; J S Neill
Journal:  Mod Pathol       Date:  2000-02       Impact factor: 7.842

4.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

5.  Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma.

Authors:  J F Henry; L Gramatica; A Denizot; A Kvachenyuk; M Puccini; T Defechereux
Journal:  Langenbecks Arch Surg       Date:  1998-04       Impact factor: 3.445

6.  Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.

Authors:  Reza Asari; Oskar Koperek; Christian Scheuba; Philipp Riss; Klaus Kaserer; Martha Hoffmann; Bruno Niederle
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

7.  The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients.

Authors:  N A Samaan; P N Schultz; R C Hickey; H Goepfert; T P Haynie; D A Johnston; N G Ordonez
Journal:  J Clin Endocrinol Metab       Date:  1992-09       Impact factor: 5.958

8.  Follicular thyroid carcinoma: histology and prognosis.

Authors:  Alessandra D'Avanzo; Patrick Treseler; Philip H G Ituarte; Mariwil Wong; Leanne Streja; Francis S Greenspan; Allan E Siperstein; Quan-Yang Duh; Orlo H Clark
Journal:  Cancer       Date:  2004-03-15       Impact factor: 6.860

9.  Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.

Authors:  Julio C Furlan; Yvan C Bedard; Irving B Rosen
Journal:  Am Surg       Date:  2007-05       Impact factor: 0.688

10.  Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern).

Authors:  Michael Rivera; R Michael Tuttle; Snehal Patel; Ashok Shaha; Jatin P Shah; Ronald A Ghossein
Journal:  Thyroid       Date:  2009-02       Impact factor: 6.568

View more
  9 in total

1.  [Current TNM system of the UICC/AJCC : the prognostic significance for differentiated thyroid carcinoma].

Authors:  M Stratmann; C Sekulla; H Dralle; M Brauckhoff
Journal:  Chirurg       Date:  2012-07       Impact factor: 0.955

2.  Minimally invasive follicular carcinoma: predictors of vascular invasion and impact on patterns of care.

Authors:  Paolo Goffredo; Christa Jillard; Samantha Thomas; Randall P Scheri; Julie Ann Sosa; Sanziana Roman
Journal:  Endocrine       Date:  2015-06-16       Impact factor: 3.633

Review 3.  The role of nuclear medicine in differentiated thyroid cancer.

Authors:  Susanne Kohlfürst
Journal:  Wien Med Wochenschr       Date:  2012-07-20

Review 4.  The Treatment of Well-Differentiated Thyroid Carcinoma.

Authors:  Ralf Paschke; Thomas Lincke; Stefan P Müller; Michael C Kreissl; Henning Dralle; Martin Fassnacht
Journal:  Dtsch Arztebl Int       Date:  2015-06-26       Impact factor: 5.594

5.  FOLLICULAR THYROID CARCINOMA - CLINICAL AND DIAGNOSTIC FINDINGS IN A 20-YEAR FOLLOW UP STUDY.

Authors:  C I Badulescu; D Piciu; D Apostu; M Badan; A Piciu
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Apr-Jun       Impact factor: 0.877

Review 6.  [Proposal for an extended pTNM classification of thyroid carcinoma : Commentary on deficits of the 8th edition of the TNM classification (German version)].

Authors:  K W Schmid; S Synoracki; H Dralle; C Wittekind
Journal:  Pathologe       Date:  2018-02       Impact factor: 1.011

7.  Minimally invasive follicular thyroid cancer (MIFTC)--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Gianlorenzo Dionigi; Jean-Louis Kraimps; Kurt Werner Schmid; Michael Hermann; Sien-Yi Sheu-Grabellus; Pierre De Wailly; Anthony Beaulieu; Maria Laura Tanda; Fausto Sessa
Journal:  Langenbecks Arch Surg       Date:  2014-02       Impact factor: 3.445

Review 8.  [Modern thyroid surgery - the surgeon's endocrine-surgical understanding and his responsibility for the extent of surgery and complication rate].

Authors:  Michael Hermann; Elisabeth Gschwandtner; Max Schneider; Laura Handgriff; Rupert Prommegger
Journal:  Wien Med Wochenschr       Date:  2020-04-27

9.  Reciprocal Dysregulation of MiR-146b and MiR-451 Contributes in Malignant Phenotype of Follicular Thyroid Tumor.

Authors:  Margarita Knyazeva; Ekaterina Korobkina; Alexey Karizky; Maxim Sorokin; Anton Buzdin; Sergey Vorobyev; Anastasia Malek
Journal:  Int J Mol Sci       Date:  2020-08-19       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.